Article Details

China Osimertinib Market Report 2021-2025: Originally TAGRISSO Developed by AstraZeneca

Retrieved on: 2021-06-03 08:26:15

Tags for this article:

Click the tags to see associated articles and topics

China Osimertinib Market Report 2021-2025: Originally TAGRISSO Developed by AstraZeneca. View article details on hiswai:

Excerpt

The original drug, TAGRISSO was developed by AstraZeneca. Osimertinib was launched in China in 2017, and it has been approved for two ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up